en

PRODUCT DETAIL

Finlee 10 mg dispergovateľné tablety

Code 5044E
MA number EU/1/23/1767/002
Product Form: tbl dsp 420 (2x210)x10 mg (fľ.HDPE + 2 odmerky)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU Orphan
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EC B-Raf serine-threonine kinase (BRAF) inhibitors
L01EC02 Dabrafenib
Shelf life: 24
Container: bottle HDPE
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10a well-established use application
MA issued: 15.11.2023
Validity: 15.11.2028
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 19.12.2023
eu-flag.png sk-flag.png